Abstract |
Multiple myeloma is not a curable disease, and most patients relapse after plateau phase. Drug resistance is a major problem in effective chemotherapy in this kind of disease. Current approaches are aimed at reversing or preventing drug resistance late in the disease. We studied a drug resistance marker, P-glycoprotein (P-gp), in a total of 43 patients with monoclonal gammopathy. This group included eight with monoclonal gammopathy of undetermined significance (MGUS), five with plasmacytoma (PCM), nineteen with multiple myeloma (MM; six newly diagnosed, seven plateau, five refractory, one relapse) and eleven amyloidosis (seven newly diagnosed, four after treatment). Using 3-color flow cytometry, a plasma cell gate was selected on the basis of CD38+/45-(dim) staining and the population was examined for the expression of P-gp using two monoclonal antibodies (MRK16 and UIC2). P-gp expression was positive on marrow plasma cells in 42/43 patients. The resistance index (RI) in these cases (range 2.0-7.07) is comparable to that in the positive cell line KG-1A (3.05-3.08). In 2 of 5 patients with refractory MM, the RI for P-gp (5.4, 6.36) was higher than in plateau phase. These data suggest that relative resistance due to the P-gp mechanism is likely to be an intrinsic property of plasma cells in monoclonal gammopathies and may provide a partial explanation as to why these diseases always relapse. The results of our study support strategies for MDR reversal earlier in the course.
|
Authors | W Mongkonsritragoon, T Kimlinger, G Ahmann, P R Greipp |
Journal | Leukemia & lymphoma
(Leuk Lymphoma)
Vol. 29
Issue 5-6
Pg. 577-84
(May 1998)
ISSN: 1042-8194 [Print] United States |
PMID | 9643571
(Publication Type: Journal Article)
|
Chemical References |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
- Antineoplastic Agents
- Neoplasm Proteins
|
Topics |
- ATP Binding Cassette Transporter, Subfamily B, Member 1
(analysis, physiology)
- Adult
- Aged
- Amyloidosis
(drug therapy, metabolism, pathology)
- Antineoplastic Agents
(therapeutic use)
- Bone Marrow
(metabolism, pathology)
- Drug Resistance, Multiple
- Female
- Humans
- Male
- Middle Aged
- Monoclonal Gammopathy of Undetermined Significance
(drug therapy, metabolism, pathology)
- Multiple Myeloma
(drug therapy, metabolism, pathology)
- Neoplasm Proteins
(analysis, physiology)
- Neoplastic Stem Cells
(metabolism, pathology)
- Plasma Cells
(metabolism, pathology)
- Plasmacytoma
(drug therapy, metabolism, pathology)
- Recurrence
- Treatment Failure
|